• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较一种新的机器学习方法与 Friedewald 公式和 Martin-Hopkins 方程在估计低密度脂蛋白方面的表现。

Comparing a novel machine learning method to the Friedewald formula and Martin-Hopkins equation for low-density lipoprotein estimation.

机构信息

Dalio Institute of Cardiovascular Imaging, Weill Cornell Medicine, New York, New York, United States of America.

Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America.

出版信息

PLoS One. 2020 Sep 30;15(9):e0239934. doi: 10.1371/journal.pone.0239934. eCollection 2020.

DOI:10.1371/journal.pone.0239934
PMID:32997716
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7526877/
Abstract

BACKGROUND

Low-density lipoprotein cholesterol (LDL-C) is a target for cardiovascular prevention. Contemporary equations for LDL-C estimation have limited accuracy in certain scenarios (high triglycerides [TG], very low LDL-C).

OBJECTIVES

We derived a novel method for LDL-C estimation from the standard lipid profile using a machine learning (ML) approach utilizing random forests (the Weill Cornell model). We compared its correlation to direct LDL-C with the Friedewald and Martin-Hopkins equations for LDL-C estimation.

METHODS

The study cohort comprised a convenience sample of standard lipid profile measurements (with the directly measured components of total cholesterol [TC], high-density lipoprotein cholesterol [HDL-C], and TG) as well as chemical-based direct LDL-C performed on the same day at the New York-Presbyterian Hospital/Weill Cornell Medicine (NYP-WCM). Subsequently, an ML algorithm was used to construct a model for LDL-C estimation. Results are reported on the held-out test set, with correlation coefficients and absolute residuals used to assess model performance.

RESULTS

Between 2005 and 2019, there were 17,500 lipid profiles performed on 10,936 unique individuals (4,456 females; 40.8%) aged 1 to 103. Correlation coefficients between estimated and measured LDL-C values were 0.982 for the Weill Cornell model, compared to 0.950 for Friedewald and 0.962 for the Martin-Hopkins method. The Weill Cornell model was consistently better across subgroups stratified by LDL-C and TG values, including TG >500 and LDL-C <70.

CONCLUSIONS

An ML model was found to have a better correlation with direct LDL-C than either the Friedewald formula or Martin-Hopkins equation, including in the setting of elevated TG and very low LDL-C.

摘要

背景

低密度脂蛋白胆固醇(LDL-C)是心血管预防的靶点。目前的 LDL-C 估算方程在某些情况下(高甘油三酯[TG]、极低 LDL-C)准确性有限。

目的

我们使用机器学习(ML)方法从标准血脂谱中利用随机森林(Weill Cornell 模型)开发了一种新的 LDL-C 估算方法。我们将其与直接 LDL-C 的相关性与 Friedewald 和 Martin-Hopkins 方程进行了比较。

方法

研究队列由标准血脂谱测量的方便样本组成(包括总胆固醇[TC]、高密度脂蛋白胆固醇[HDL-C]和 TG 的直接测量成分)以及在纽约长老会医院/威尔康奈尔医学中心(NYP-WCM)同一天进行的基于化学的直接 LDL-C。随后,使用 ML 算法构建 LDL-C 估算模型。结果在保留的测试集上报告,使用相关系数和绝对残差来评估模型性能。

结果

在 2005 年至 2019 年期间,在 10936 名不同个体(44.56%为女性)中进行了 17500 次血脂谱测量。估算的 LDL-C 值与实测 LDL-C 值之间的相关系数分别为 Weill Cornell 模型为 0.982,Friedewald 方程为 0.950,Martin-Hopkins 法为 0.962。Weill Cornell 模型在按 LDL-C 和 TG 值分层的亚组中始终表现更好,包括 TG>500 和 LDL-C<70。

结论

与 Friedewald 公式或 Martin-Hopkins 方程相比,ML 模型与直接 LDL-C 的相关性更好,包括在 TG 升高和 LDL-C 极低的情况下。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/641b/7526877/473dcba3ef07/pone.0239934.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/641b/7526877/9a55ac4a7591/pone.0239934.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/641b/7526877/22f620c27cad/pone.0239934.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/641b/7526877/473dcba3ef07/pone.0239934.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/641b/7526877/9a55ac4a7591/pone.0239934.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/641b/7526877/22f620c27cad/pone.0239934.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/641b/7526877/473dcba3ef07/pone.0239934.g003.jpg

相似文献

1
Comparing a novel machine learning method to the Friedewald formula and Martin-Hopkins equation for low-density lipoprotein estimation.比较一种新的机器学习方法与 Friedewald 公式和 Martin-Hopkins 方程在估计低密度脂蛋白方面的表现。
PLoS One. 2020 Sep 30;15(9):e0239934. doi: 10.1371/journal.pone.0239934. eCollection 2020.
2
Comparison of Low-Density Lipoprotein Cholesterol Assessment by Martin/Hopkins Estimation, Friedewald Estimation, and Preparative Ultracentrifugation: Insights From the FOURIER Trial.马丁/霍普金斯估计、弗里德瓦尔德估计和制备超速离心法评估低密度脂蛋白胆固醇的比较: FOURIER 试验的见解。
JAMA Cardiol. 2018 Aug 1;3(8):749-753. doi: 10.1001/jamacardio.2018.1533.
3
Comparison of Methods to Estimate Low-Density Lipoprotein Cholesterol in Patients With High Triglyceride Levels.比较高甘油三酯血症患者估算低密度脂蛋白胆固醇的方法。
JAMA Netw Open. 2021 Oct 1;4(10):e2128817. doi: 10.1001/jamanetworkopen.2021.28817.
4
Comparability of 11 different equations for estimating LDL cholesterol on different analysers.比较不同分析仪上 11 种不同 LDL 胆固醇估算方程的可比性。
Clin Chem Lab Med. 2021 Aug 12;59(12):1930-1943. doi: 10.1515/cclm-2021-0747. Print 2021 Nov 25.
5
Discordance Between Standard Equations for Determination of LDL Cholesterol in Patients With Atherosclerosis.动脉粥样硬化患者 LDL 胆固醇测定的标准方程之间的差异。
J Am Coll Cardiol. 2022 Feb 15;79(6):530-541. doi: 10.1016/j.jacc.2021.11.042.
6
Comparing a novel equation for calculating low-density lipoprotein cholesterol with the Friedewald equation: A VOYAGER analysis.将一种计算低密度脂蛋白胆固醇的新方程与Friedewald方程进行比较:VOYAGER分析。
Clin Biochem. 2019 Feb;64:24-29. doi: 10.1016/j.clinbiochem.2018.10.011. Epub 2018 Oct 24.
7
Comparison of low-density lipoprotein cholesterol level calculated using the modified Martin/Hopkins estimation or the Friedewald formula with direct homogeneous assay measured low-density lipoprotein cholesterol.使用改良的Martin/Hopkins估算方法或Friedewald公式计算的低密度脂蛋白胆固醇水平与直接匀相测定法测得的低密度脂蛋白胆固醇水平的比较。
Arch Med Sci. 2020 Aug 3;18(3):577-586. doi: 10.5114/aoms.2020.97847. eCollection 2022.
8
Evaluation of low-density lipoprotein cholesterol equations by cross-platform assessment of accuracy-based EQA data against SI-traceable reference value.基于与 SI 可溯源参考值的准确性的 EQA 数据的跨平台评估来评价 LDL-C 方程。
Clin Chem Lab Med. 2023 Apr 4;61(10):1808-1819. doi: 10.1515/cclm-2022-1301. Print 2023 Sep 26.
9
Validation of Friedewald, Martin-Hopkins and Sampson low-density lipoprotein cholesterol equations.验证 Friedewald、Martin-Hopkins 和 Sampson 低密度脂蛋白胆固醇方程。
PLoS One. 2022 May 13;17(5):e0263860. doi: 10.1371/journal.pone.0263860. eCollection 2022.
10
Correlation of extended Martin/Hopkins equation with a direct homogeneous assay in assessing low-density lipoprotein cholesterol in patients with hypertriglyceridemia.扩展的 Martin/Hopkins 方程与直接均相法评估高甘油三酯血症患者的低密度脂蛋白胆固醇的相关性。
J Clin Lab Anal. 2023 Sep;37(17-18):e24963. doi: 10.1002/jcla.24963. Epub 2023 Sep 7.

引用本文的文献

1
Integrating New Technologies in Lipidology: A Comprehensive Review.脂质学中新技术的整合:全面综述
J Clin Med. 2025 Jul 14;14(14):4984. doi: 10.3390/jcm14144984.
2
Machine learning-based prediction of LDL cholesterol: performance evaluation and validation.基于机器学习的低密度脂蛋白胆固醇预测:性能评估与验证
PeerJ. 2025 Apr 9;13:e19248. doi: 10.7717/peerj.19248. eCollection 2025.
3
Assessing Performance of Martins's and Sampson's Formulae for Calculation of LDL-C in Indian Population: A Single Center Retrospective Study.

本文引用的文献

1
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2018年美国心脏协会/美国心脏病学会/美国心血管和肺康复协会/美国医师助理学会/美国心脏协会/美国预防医学学会/美国糖尿病协会/美国老年医学会/美国药剂师协会/美国临床内分泌医师协会/美国国家脂质协会/美国初级保健医师学会血胆固醇管理指南:执行摘要:美国心脏病学会/美国心脏协会临床实践指南工作组报告
J Am Coll Cardiol. 2019 Jun 25;73(24):3168-3209. doi: 10.1016/j.jacc.2018.11.002. Epub 2018 Nov 10.
2
Efficacy and Safety of Further Lowering of Low-Density Lipoprotein Cholesterol in Patients Starting With Very Low Levels: A Meta-analysis.进一步降低起始低密度脂蛋白胆固醇水平非常低的患者的 LDL 胆固醇的疗效和安全性:一项荟萃分析。
JAMA Cardiol. 2018 Sep 1;3(9):823-828. doi: 10.1001/jamacardio.2018.2258.
3
评估马丁斯公式和桑普森公式在印度人群中计算低密度脂蛋白胆固醇(LDL-C)的性能:一项单中心回顾性研究。
Indian J Clin Biochem. 2024 Oct;39(4):579-585. doi: 10.1007/s12291-023-01142-3. Epub 2023 Jul 7.
4
Applicability of Artificial Intelligence in the Field of Clinical Lipidology: A Narrative Review.人工智能在临床脂质学领域的适用性:一篇叙述性综述。
J Lipid Atheroscler. 2024 May;13(2):111-121. doi: 10.12997/jla.2024.13.2.111. Epub 2024 Feb 27.
5
Exploring alternative approaches to precision medicine through genomics and artificial intelligence - a systematic review.通过基因组学和人工智能探索精准医学的替代方法——一项系统综述
Front Med (Lausanne). 2023 Oct 2;10:1227168. doi: 10.3389/fmed.2023.1227168. eCollection 2023.
6
Comparison of Newly Proposed LDL-Cholesterol Estimation Equations.比较新提出的 LDL-胆固醇估算方程。
J Korean Med Sci. 2023 May 15;38(19):e145. doi: 10.3346/jkms.2023.38.e145.
7
The Impact of Low-Density Lipoprotein Equation Changes on Cholesterol Treatment in Canada.低密度脂蛋白方程变化对加拿大胆固醇治疗的影响。
CJC Open. 2022 Oct 1;5(1):37-42. doi: 10.1016/j.cjco.2022.09.007. eCollection 2023 Jan.
8
Comparison of a Machine Learning Method and Various Equations for Estimating Low-Density Lipoprotein Cholesterol in Korean Populations.韩国人群中用于估计低密度脂蛋白胆固醇的机器学习方法与各种方程的比较。
Front Cardiovasc Med. 2022 Feb 10;9:824574. doi: 10.3389/fcvm.2022.824574. eCollection 2022.
9
An architecture for research computing in health to support clinical and translational investigators with electronic patient data.用于健康研究计算的架构,以支持临床和转化研究人员使用电子患者数据。
J Am Med Inform Assoc. 2022 Mar 15;29(4):677-685. doi: 10.1093/jamia/ocab266.
Secondary Use of Patients' Electronic Records (SUPER): An Approach for Meeting Specific Data Needs of Clinical and Translational Researchers.患者电子记录的二次利用(SUPER):一种满足临床和转化研究人员特定数据需求的方法。
AMIA Annu Symp Proc. 2018 Apr 16;2017:1581-1588. eCollection 2017.
4
No evidence of neurocognitive adverse events associated with alirocumab treatment in 3340 patients from 14 randomized Phase 2 and 3 controlled trials: a meta-analysis of individual patient data.在 14 项随机的 2 期和 3 期对照临床试验的 3340 例患者中,没有发现与阿利西尤单抗治疗相关的神经认知不良事件:一项个体患者数据的荟萃分析。
Eur Heart J. 2018 Feb 1;39(5):374-381. doi: 10.1093/eurheartj/ehx661.
5
Prognostic Value of Combined Clinical and Myocardial Perfusion Imaging Data Using Machine Learning.采用机器学习方法的联合临床和心肌灌注成像数据的预后价值。
JACC Cardiovasc Imaging. 2018 Jul;11(7):1000-1009. doi: 10.1016/j.jcmg.2017.07.024. Epub 2017 Oct 18.
6
Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up.男性原发性低密度脂蛋白胆固醇水平升高至 190mg/dL 或以上的心血管疾病一级预防中降低低密度脂蛋白胆固醇:来自 WOSCOPS(苏格兰西部冠状动脉预防研究)5 年随机试验和 20 年观察随访的分析。
Circulation. 2017 Nov 14;136(20):1878-1891. doi: 10.1161/CIRCULATIONAHA.117.027966. Epub 2017 Sep 6.
7
Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial.PCSK9 抑制剂依洛尤单抗降低 LDL-胆固醇水平的临床疗效和安全性:FOURIER 试验的预先设定的次要分析。
Lancet. 2017 Oct 28;390(10106):1962-1971. doi: 10.1016/S0140-6736(17)32290-0. Epub 2017 Aug 28.
8
Evaluating the atherogenic burden of individuals with a Friedewald-estimated low-density lipoprotein cholesterol <70 mg/dL compared with a novel low-density lipoprotein estimation method.评估 Friedewald 估计的低密度脂蛋白胆固醇 <70mg/dL 的个体与新型低密度脂蛋白估计方法相比的动脉粥样硬化负担。
J Clin Lipidol. 2017 Jul-Aug;11(4):1065-1072. doi: 10.1016/j.jacl.2017.05.005. Epub 2017 Jun 1.
9
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel.低密度脂蛋白导致动脉粥样硬化性心血管疾病。1. 来自遗传、流行病学和临床研究的证据。欧洲动脉粥样硬化学会共识小组的共识声明。
Eur Heart J. 2017 Aug 21;38(32):2459-2472. doi: 10.1093/eurheartj/ehx144.
10
Accuracy of low-density lipoprotein cholesterol estimation at very low levels.极低水平低密度脂蛋白胆固醇估计值的准确性。
BMC Med. 2017 Apr 20;15(1):83. doi: 10.1186/s12916-017-0852-2.